Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).

Authors

Alice C Shapiro
Susan A Adlis
Kim Robien, George Washington UniversityFollow
Mark N Kirstein
Shuang Liang
Sara A Richter
Rachel E Lerner

Document Type

Journal Article

Publication Date

2-1-2016

Journal

Breast Cancer Research and Treatment

Volume

155

Issue

3

Inclusive Pages

501-512

DOI

10.1007/s10549-016-3710-6

Keywords

Aromatase Inhibitors--adverse effects; Arthralgia--drug therapy; Breast Neoplasms--drug therapy; Cholecalciferol--administration & dosage; Musculoskeletal Diseases--drug therapy

APA Citation

Shapiro, A., Adlis, S., Robien, K., Kirstein, M., Liang, S., Richter, S., & Lerner, R. (2016). Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).. Breast Cancer Research and Treatment, 155 (3). http://dx.doi.org/10.1007/s10549-016-3710-6

Peer Reviewed

1